Skip to main content

IBC Drug & Alcohol Testing Branch Quarterly Newsletter - FY 2023 Q3

Transition from eDrug to MYeSCREEN

The edrugtest.com website you use to schedule and track drug tests will be sunset this fiscal year. Abbott and the IBC Drug & Alcohol Testing Branch are working on this migration process. In the future, you will get instructions on how to log in and use the new website: myescreen.com


What to expect with the transition

At a future date, you will be provided with a new userid into myescreen.com. To log in to myescreen.com, you will be routed to login.gov to authenticate your identity. You can use several methods to authenticate; your cell number, your PIV/CAC card, or an authenticator application. After authentication, you'll gain access to myescreen.com. Once in myescreen, you will be able to schedule and track tests and access historic testing data that was in edrugtest.com.


Why the transition to websites is necessary

The transition off the edrugtest environment is necessary to satisfy multi-factor authentication requirements for how users access the data. Also, myescreen is a more robust site that has improved functionality. Lastly, edrugtest is being decommissioned.

 

Last Updated: